Stay updated with breaking news from 39 Breakthrough. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.
Liquid biopsy specialist Angle described a “breakthrough year” in its 2022 results on Friday, with both FDA clearance and positive results from the ovarian cancer study being achieved.